Département de Chirurgie Hépato-Biliaire, Centre Hépato-Biliaire, IFR 89.9, France.
HPB (Oxford). 2010 Sep;12(7):439-46. doi: 10.1111/j.1477-2574.2010.00194.x.
Ischaemic preconditioning (IPC) of the right liver graft in the donor has not been studied in adult-to-adult living related liver transplantation (LRLT).
To assess the IPC effect of the graft on ischaemia reperfusion injury in the recipient and compare recipient and donor outcomes with and without preconditioned grafts.
Alternate patients were transplanted with right lobe grafts that were (n = 22; Group (Precond)) or were not (n = 22; Group (Control)) subjected to IPC in the living donor. Liver ischaemia-reperfusion injury, liver/kidney function, morbidity/mortality rates and outcomes were compared. Univariate and multivariate analyses were performed to identify factors predictive of the aspartate aminotransferase (AST) peak and minimum prothrombin time.
Both groups had similar length of hospital stay, morbidity/mortality, primary non-function and acute rejection rates. Post-operative AST (P = 0.8) and alanine aminotransferase (ALT) peaks (P = 0.6) were similar in both groups (307 +/- 189 and 437 +/- 302 vs. 290 +/- 146 and 496 +/- 343, respectively). In univariate analysis, only pre-operative AST and warm ischemia time (WIT) were significantly associated with post-operative AST peak (in recipients). In multivariate analysis, the graft/recipient weight ratio (P = 0.003) and pre-operative bilirubin concentration (P = 0.004) were significantly predictive of minimum prothrombin time post-transplantation.
Graft IPC in the living related donor is not associated with any benefit for the recipient or the donor and its clinical value remains uncertain.
在成人活体肝移植(LRLT)中,尚未研究供体右肝移植物的缺血预处理(IPC)。
评估供体移植物对受体缺血再灌注损伤的 IPC 效果,并比较有无预处理移植物的受体和供体的结果。
交替患者接受了右叶移植物的移植,这些移植物在活体供体中(n = 22;预处理组(Precond))或未进行 IPC(n = 22;对照组(Control))。比较了肝缺血再灌注损伤、肝/肾功能、发病率/死亡率和结果。进行了单变量和多变量分析,以确定预测天冬氨酸氨基转移酶(AST)峰值和最小凝血酶原时间的因素。
两组的住院时间、发病率/死亡率、原发性无功能和急性排斥反应率相似。两组术后 AST(P = 0.8)和丙氨酸氨基转移酶(ALT)峰值(P = 0.6)相似(分别为 307 +/- 189 和 437 +/- 302 vs. 290 +/- 146 和 496 +/- 343)。在单变量分析中,只有术前 AST 和热缺血时间(WIT)与术后 AST 峰值显著相关(在受体中)。在多变量分析中,移植物/受体重量比(P = 0.003)和术前胆红素浓度(P = 0.004)是移植后最小凝血酶原时间的显著预测因素。
活体供体移植物的 IPC 对受体或供体均无益处,其临床价值仍不确定。